Dr. Franz Kricek (Ph.D.)
|Since 1980||Dr. Franz Kricek holds a Ph.D. in Chemistry and Biochemistry from the Technical University of Vienna|
|1975-1977||Teacher for Chemistry and Physics, Piaristengymnasium Krems, Austria|
|1980||Postdoctoral Fellow, Sandoz Research Institute, Vienna|
|1983||Laboratory Head, Sandoz / Novartis Research Institute, Vienna|
|1990-1996||Executive Board Member, Austrian Society for Genetics and Gene Technology|
|1997||Project Team Head and international project team research representative for various Novartis research and development projects (University of Berne, Switzerland; The Scripps Institute, USA)|
|2000||Novartis Leading Scientist|
|2004||Laboratory Head Biology I; disease area: respiratory diseases (RD-ADV); Project Team Head|
|2009||CEO of NBS-C BioScience & Consulting GmbH|
Professional interests: Molecular Biology, (first introduction and establishment of recombinant DNA technology at Sandoz Research Institute Vienna), gene expression/ protein purification, phage display technology; immunological in-vitro methods, cell culture, surface plasmon resonance technology.
Editorial Board: The Open Allergy Journal (Bentham Science Publishers).
Dr. Herbert Syrowatka (PH.D.)
|Since 1969||Dr. Herbert Syrowatka holds a Ph.D. in Organic Chemistry from the University Vienna|
|1970||Head of QC department "Heilmittelwerke Wien"|
|1972||Boehringer Ingelheim Austria GmbH as Head of QC, notified to the Austrian authorities as a "Kontrollleiter" and later also as a Qualified Person|
|1995-1998||Lecturer at the Pharmaceutical Institute of the University Vienna|
|2002||GMP project for Boehringer Ingelheim South Korea|
Founder and proprietor of QSC - Quality Systems Consulting GmbH.